Media Report | Jacobio Pharma

5 press releases in total

2023

Aug 10, 2023

Glecirasib Receives Breakthrough Therapy Designation in China for KRAS G12C–Mutated Pancreatic Cancer

2021

Jul 9, 2021

China Daily: Drugmakers increasingly looking abroad

2020

Dec 22, 2020

Bloomberg: Jacobio Pharmaceuticals CEO Dr. Wang Yinxiang on Hong Kong IPO
Dec 21, 2020

BioWorld: Jacobio launches $174M IPO in Hong Kong, advances SHP2 programs
Jun 1, 2020

Fierce Biotech: AbbVie pens cancer pact with U.S.-China biotech Jacobio